FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Zydus Pharmaceuticals (USA) Cyanocobalamin Injection Recall

Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactu…

Zydus Pharmaceuticals (USA) Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Jul 24, 2024
Recall ID
D-0600-2024
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals (USA) recalled Cyanocobalamin Injection starting Jun 27, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0600-2024 on Jul 24, 2024. Reason: Presence of particulate matter: glass. Status: Terminated.

Why it was recalled

Presence of particulate matter: glass

Product description

Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN, 38141, Mfd. in India, NDC 16714-165-01.

Lot numbers, UPCs & expiration codes

Lot #: L200253, L200281, L200301, Exp 07/31/2024

Where it was sold

TN

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0600-2024
Classification
Class II
Status
Terminated
Recall initiated
Jun 27, 2024
FDA report date
Jul 24, 2024
Quantity
432250 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals (USA) Inc

Original FDA data

Every field from FDA enforcement report D-0600-2024, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
94914
Address
73 Route 31 N
Code information
Lot #: L200253, L200281, L200301, Exp 07/31/2024
Postal code
08534-3601
Report date
Jul 24, 2024
Product type
Drugs
Recall number
D-0600-2024
Classification
Class II
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Product quantity
432250 vials
Termination date
Sep 4, 2025
Reason for recall
Presence of particulate matter: glass
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN, 38141, Mfd. in India, NDC 16714-165-01.
Distribution pattern
TN
Recall initiation date
Jun 27, 2024
Initial firm notification
Letter
Center classification date
Jul 16, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0600-2024, published Jul 24, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls